Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians

@article{Qaseem2011VenousTP,
  title={Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians},
  author={Amir Qaseem and Roger Chou and Linda L. Humphrey and Melissa Starkey and Paul Shekelle},
  journal={Annals of Internal Medicine},
  year={2011},
  volume={155},
  pages={625 - 632}
}
DESCRIPTION The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on prophylaxis of venous thromboembolism for hospitalized nonsurgical patients (medical patients and patients with acute stroke). METHODS This guideline is based on published literature on the topic from 1950 through April 2011 that was identified by using MEDLINE, the Cochrane Library, and reference lists of pertinent randomized trials and systematic… Expand
A Review of Venous Thromboembolism Prophylaxis for Hospitalized Medical Patients
TLDR
This work provides a comprehensive evidence-based clinical review of VTE prophylaxis for nonsurgical hospitalized patients, including risk factors and risk assessment, indications for proplylaxis, recommended therapeutic options, and updates from recently released practice guidelines by the American College of Physicians and the American Chest Physicians. Expand
Prophylaxis against venous thromboembolism in hospitalized medically ill patients: Update and practical approach.
  • R. Camden, S. Ludwig
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2014
TLDR
The use of study enrollment criteria and patient demographics, including special population considerations, can provide guidance for risk determination and allow for an evidence-based approach to identifying eligible patients for prophylaxis. Expand
Venous thromboembolism prophylaxis in hospitalized medical patients.
TO THE EDITOR: There seems to be a disconnect between the evidence-based guidelines from the American College of Physicians (ACP) (1) and its background review by Lederle and colleagues (2). It isExpand
Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients
  • G. Mills
  • Medicine
  • Annals of Internal Medicine
  • 2012
TO THE EDITOR: There seems to be a disconnect between the evidence-based guidelines from the American College of Physicians (ACP) (1) and its background review by Lederle and colleagues (2). It isExpand
Venous thromboembolism prevention guidelines for medical inpatients: mind the (implementation) gap.
TLDR
Simpler VTE risk-assessment models may be superior to complicated point-based models in environments without sophisticated clinical decision support and provide varied guidance on important issues including risk assessment. Expand
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.
TLDR
These evidence-based guidelines from the American Society of Hematology intend to support patients, clinicians, and others in decisions about preventing VTE in medical inpatients and outpatients with minor injuries and long-distance travelers. Expand
Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
TLDR
In acutely ill inpatients with sepsis, no significant benefit was demonstrated for VTE prophylaxis, with higher rates of bleeding, and the risk-benefit ratio of this intervention should be carefully examined. Expand
Venous Thromboembolism Prophylaxis in Acute Medically ill Patients: A Retrospective Cohort Study.
TLDR
The current practice of routinely administering venous thromboembolism prophylaxis to medically ill patients considered at highrisk for thrombosis, resulted in a high risk for bleeding without a clear clinical benefit, and should be reassessed. Expand
Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review
TLDR
A systematic review of published risk-assessment models for VTE to determine whether any RAM is validated sufficiently to be employed in clinical practice found 11 RAMs were identified, but the number, types, and strength of association of VTE risk predictors were highly variable. Expand
Prophylaxis of Venous Thromboembolism in Home Care: An Integrative Review
TLDR
Evidence regarding prophylaxis of VTE in home care is identified by searching the databases PubMed/Medline, LILACS, and National Guideline Clearinghouse for articles published between January 1985 and June 2015. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 61 REFERENCES
Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients
  • G. Mills
  • Medicine
  • Annals of Internal Medicine
  • 2012
TO THE EDITOR: There seems to be a disconnect between the evidence-based guidelines from the American College of Physicians (ACP) (1) and its background review by Lederle and colleagues (2). It isExpand
The prophylaxis of medical patients for thromboembolism pilot study.
TLDR
The pilot study indicated that the full study was not feasible, and the effect of low-dose heparin prophylaxis on clinical outcomes in hospitalized general medical patients remains uncertain. Expand
Current Diagnosis of Venous Thromboembolism in Primary Care: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians*
TLDR
Validated clinical prediction rules should be used to estimate pretest probability of venous thromboembolism (VTE), both deep venous Thrombosis (DVT) and pulmonary embolism, and for the basis of interpretation of subsequent tests. Expand
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
TLDR
The findings do not support the routine use of heparin prophylaxis for 3 weeks or less in large groups of non-surgical patients, and further studies are needed to investigate whether heparins of longer duration may prevent fatal pulmonary embolism. Expand
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy:Expand
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
TLDR
Fondaparinux is effective in the prevention of asymptomatic and symptomatic venous thromboembolic events in older acute medical patients. Expand
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
TLDR
Dalteparin 5000 IU once daily halved the rate of venous thromboembolism with a low risk of bleeding and was maintained at 90 days. Expand
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
TLDR
Prophylactic treatment with 40 mg of enoxaparin subcutaneously per day safely and effectively reduces the risk of venous thromboembolism in patients with acute medical illnesses. Expand
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.
TLDR
The findings do not support the routine use of heparin prophylaxis for 3 weeks or less in large groups of non-surgical patients and further studies are needed to investigate whether heparins of longer duration may prevent fatal pulmonary embolism. Expand
[Two models of thromboprophylaxis in acutely ill medical inpatients].
TLDR
The study confirmed the effectiveness and safety of thromboprophylaxis with nadroparin in acutely ill medical inpatients, suggesting additional benefits from prolonged use of low molecular weight heparins observed during the first months after hospitalization. Expand
...
1
2
3
4
5
...